Status:
COMPLETED
Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol
Lead Sponsor:
Gynuity Health Projects
Conditions:
Abortion, First Trimester
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study examined the acceptability and feasibility of introducing a mifepristone-misoprostol regimen of medical abortion into abortion services in two private clinics in Puerto Rico; 2 clinics in B...
Detailed Description
The study recruited women with pregnancies up to 63 days gestation. Eligible women took 200 mg mifepristone, followed by 800 buccal misoprostol. They later underwent clinic follow-up to determine if t...
Eligibility Criteria
Inclusion
- Gestation up to 63 days
- General good health
- Willingness to provide contact information for follow-up
- Absence of conditions which contraindicate the use of mifepristone and misoprostol for pregnancy termination
Exclusion
- Ectopic pregnancy
- Intrauterine device (IUD) in place
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT00386282
Start Date
September 1 2006
End Date
March 1 2011
Last Update
July 30 2014
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Family Planning and Sexual Health
Yerevan, Armenia
2
Institute of Perinatology, Obstetrics and Gynecology
Yerevan, Armenia
3
State Medical University
Yerevan, Armenia
4
Family Planning Center
Baku, Azerbaijan